SE9703693D0 - Novel combination - Google Patents

Novel combination

Info

Publication number
SE9703693D0
SE9703693D0 SE9703693A SE9703693A SE9703693D0 SE 9703693 D0 SE9703693 D0 SE 9703693D0 SE 9703693 A SE9703693 A SE 9703693A SE 9703693 A SE9703693 A SE 9703693A SE 9703693 D0 SE9703693 D0 SE 9703693D0
Authority
SE
Sweden
Prior art keywords
pct
date
novel combination
inhibitor
sec
Prior art date
Application number
SE9703693A
Other languages
English (en)
Swedish (sv)
Inventor
Peter Hamley
Alan Tinker
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9703693A priority Critical patent/SE9703693D0/xx
Publication of SE9703693D0 publication Critical patent/SE9703693D0/xx
Priority to CA002305141A priority patent/CA2305141A1/en
Priority to CZ20001272A priority patent/CZ20001272A3/cs
Priority to HU0003874A priority patent/HUP0003874A2/hu
Priority to EEP200000192A priority patent/EE200000192A/xx
Priority to US09/171,801 priority patent/US6046191A/en
Priority to BR9812753-5A priority patent/BR9812753A/pt
Priority to IL13524898A priority patent/IL135248A0/xx
Priority to PL98339769A priority patent/PL339769A1/xx
Priority to CN98812081A priority patent/CN1281362A/zh
Priority to PCT/SE1998/001792 priority patent/WO1999018960A1/en
Priority to SK428-2000A priority patent/SK4282000A3/sk
Priority to TR2000/00928T priority patent/TR200000928T2/tr
Priority to EP98948031A priority patent/EP1027052A1/en
Priority to AU94693/98A priority patent/AU9469398A/en
Priority to MXPA00003445 priority patent/MXPA00003445A/es
Priority to KR1020007003824A priority patent/KR20010031017A/ko
Priority to JP2000515595A priority patent/JP2001519391A/ja
Priority to IS5430A priority patent/IS5430A/is
Priority to NO20001830A priority patent/NO20001830L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
SE9703693A 1997-10-10 1997-10-10 Novel combination SE9703693D0 (sv)

Priority Applications (20)

Application Number Priority Date Filing Date Title
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination
JP2000515595A JP2001519391A (ja) 1997-10-10 1998-10-05 新規な組み合わせ物
PL98339769A PL339769A1 (en) 1997-10-10 1998-10-05 Novel combination
PCT/SE1998/001792 WO1999018960A1 (en) 1997-10-10 1998-10-05 Novel combination
HU0003874A HUP0003874A2 (hu) 1997-10-10 1998-10-05 Gyulladáscsökkentő hatású gyógyszerkombináció
EEP200000192A EE200000192A (et) 1997-10-10 1998-10-05 Uus kombinatsioon
US09/171,801 US6046191A (en) 1997-10-10 1998-10-05 Combination
BR9812753-5A BR9812753A (pt) 1997-10-10 1998-10-05 Combinação farmacêutica, uso da mesma, processo para tratamento de uma doença inflamatória, e, composição farmacêutica
IL13524898A IL135248A0 (en) 1997-10-10 1998-10-05 Novel combination
CA002305141A CA2305141A1 (en) 1997-10-10 1998-10-05 Novel combination
CN98812081A CN1281362A (zh) 1997-10-10 1998-10-05 新的联合用药物
CZ20001272A CZ20001272A3 (cs) 1997-10-10 1998-10-05 Nová kombinace
SK428-2000A SK4282000A3 (en) 1997-10-10 1998-10-05 Pharmaceutical combinations
TR2000/00928T TR200000928T2 (tr) 1997-10-10 1998-10-05 Yeni kombinasyon.
EP98948031A EP1027052A1 (en) 1997-10-10 1998-10-05 Novel combination
AU94693/98A AU9469398A (en) 1997-10-10 1998-10-05 Novel combination
MXPA00003445 MXPA00003445A (es) 1997-10-10 1998-10-05 Combinacion de un inhibidor de sintetasa de oxido nitrico inducida y un inhibidor de ciclooxigenas
KR1020007003824A KR20010031017A (ko) 1997-10-10 1998-10-05 신규 제약 제제
IS5430A IS5430A (is) 1997-10-10 2000-04-06 Ný samsetning
NO20001830A NO20001830L (no) 1997-10-10 2000-04-07 Ny kombinasjon

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination

Publications (1)

Publication Number Publication Date
SE9703693D0 true SE9703693D0 (sv) 1997-10-10

Family

ID=20408563

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9703693A SE9703693D0 (sv) 1997-10-10 1997-10-10 Novel combination

Country Status (20)

Country Link
US (1) US6046191A (tr)
EP (1) EP1027052A1 (tr)
JP (1) JP2001519391A (tr)
KR (1) KR20010031017A (tr)
CN (1) CN1281362A (tr)
AU (1) AU9469398A (tr)
BR (1) BR9812753A (tr)
CA (1) CA2305141A1 (tr)
CZ (1) CZ20001272A3 (tr)
EE (1) EE200000192A (tr)
HU (1) HUP0003874A2 (tr)
IL (1) IL135248A0 (tr)
IS (1) IS5430A (tr)
MX (1) MXPA00003445A (tr)
NO (1) NO20001830L (tr)
PL (1) PL339769A1 (tr)
SE (1) SE9703693D0 (tr)
SK (1) SK4282000A3 (tr)
TR (1) TR200000928T2 (tr)
WO (1) WO1999018960A1 (tr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9701304D0 (sv) * 1997-04-09 1997-04-09 Astra Pharma Prod Compounds
HRP20010099A2 (en) * 1998-08-11 2002-02-28 Pfizer Prod Inc New pharmaceutical uses for nos inhibitors
EA008242B1 (ru) 1999-12-08 2007-04-27 Фармация Корпорейшн Композиции на основе ингибитора циклооксигеназы-2 с быстро наступающим терапевтическим действием и способы лечения заболеваний
US6649629B2 (en) 1999-12-23 2003-11-18 Nitromed, Inc. Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
GB0004153D0 (en) * 2000-02-23 2000-04-12 Astrazeneca Uk Ltd Novel use
US6800297B2 (en) * 2000-06-15 2004-10-05 Acusphere, Inc. Porous COX-2 inhibitor matrices and methods of manufacture thereof
US6589557B2 (en) * 2000-06-15 2003-07-08 Acusphere, Inc. Porous celecoxib matrices and methods of manufacture thereof
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
WO2002017896A2 (en) * 2000-08-29 2002-03-07 Peter Van Patten Combination for the treatment of migraine comprising a cyclooxygenase-2 inhibitor and acetylsalicylic acid
IN191090B (tr) * 2000-08-29 2003-09-20 Ranbanx Lab Ltd
US7012098B2 (en) * 2001-03-23 2006-03-14 Pharmacia Corporation Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers
US20030035795A1 (en) * 2001-04-13 2003-02-20 Gardell Stephen J. Methods for treating or reducing the risk of pain and inflammatory disorders by administering inhibitors of activated thrombin activatable fibrinolysis inhibitor
US20020187187A1 (en) * 2001-04-21 2002-12-12 Toshimitsu Ohki Fast disintegrating meloxicam tablet
AR035700A1 (es) * 2001-05-08 2004-06-23 Astrazeneca Ab Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados
US20030114418A1 (en) * 2001-08-14 2003-06-19 Pharmacia Corporation Method for the treatment and prevention of pain and inflammation with glucosamine and a cyclooxygenase-2 selective inhibitor and compositions therefor
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
EP1448209A2 (en) * 2001-10-23 2004-08-25 Ranbaxy Laboratories, Ltd. A process for the preparation of pharmaceutical compositions for topical delivery of cyclooxygenase-2 enzyme inhibitors
US20030100595A1 (en) * 2001-11-13 2003-05-29 Aziz Karim Oral dosage form of a sulfonamide prodrug
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
KR20050005410A (ko) * 2002-02-19 2005-01-13 파마시아 코포레이션 요실금 치료용으로서의 시클로옥시게나제 저해제 및항무스카린제의 용도
US7220749B2 (en) * 2002-06-11 2007-05-22 Nitromed, Inc. Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
AU2003261281A1 (en) * 2002-07-29 2004-02-16 Nicox S.A. Cyclooxygenase- 2 selective inhibitors, compositions and methods of use
US8992980B2 (en) * 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
ES2275218T3 (es) * 2003-05-07 2007-06-01 Osteologix A/S Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
SI1622630T1 (sl) * 2003-05-07 2012-12-31 Osteologix A/S Stroncijeva kombinacije za profilakso/zdravljenje patologij hrustanca in/ali kosti
EP1568369A1 (en) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
AU2005254154A1 (en) * 2004-06-17 2005-12-29 Osteologix A/S Improving pain treatment with strontium combinations
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
EP2612854B1 (en) 2005-10-25 2015-04-29 Shionogi&Co., Ltd. Aminothiazolidine and aminotetrahydrothiazepine derivatives as BACE 1 inhibitors
JP2007275193A (ja) * 2006-04-04 2007-10-25 Fujifilm Corp 光プローブおよび光断層画像化装置
GB0712287D0 (en) * 2007-06-22 2007-08-01 Ucl Business Plc Antimicrobial Conjugates
WO2008015445A2 (en) * 2006-08-04 2008-02-07 Ucl Business Plc Computer devices and accessories
CA2676413A1 (en) * 2007-01-19 2008-07-31 Mallinckrodt Inc. Diagnostic and therapeutic cyclooxygenase-2 binding ligands
WO2008133273A1 (ja) 2007-04-24 2008-11-06 Shionogi & Co., Ltd. アルツハイマー症治療用医薬組成物
TW200902526A (en) 2007-04-24 2009-01-16 Shionogi & Amp Co Ltd Aminodihydrothiazin derivative substituted with a cyclic group
DE102007049612A1 (de) * 2007-10-17 2009-06-10 Evonik Goldschmidt Gmbh Bioaktive Zusammensetzung für kosmetische Anwendungen
WO2009151098A1 (ja) 2008-06-13 2009-12-17 塩野義製薬株式会社 βセクレターゼ阻害作用を有する含硫黄複素環誘導体
JPWO2010047372A1 (ja) 2008-10-22 2012-03-22 塩野義製薬株式会社 Ｂａｃｅ１阻害活性を有する２−アミノピリミジン−４−オンおよび２−アミノピリジン誘導体
MX2012004177A (es) 2009-10-12 2012-05-08 Boehringer Ingelheim Vetmed Recipiente para composiciones que comprenden meloxicam.
UA110467C2 (uk) 2009-12-11 2016-01-12 Шионогі Енд Ко., Лтд. Похідні оксазину
US9149480B2 (en) 2010-03-03 2015-10-06 Boehringer Ingeleheim Vetmedica GmbH Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
EP2634188A4 (en) 2010-10-29 2014-05-07 Shionogi & Co FUSIONED AMINODIHYDROPYRIMIDINE DERIVATIVE
CN103261199A (zh) 2010-10-29 2013-08-21 盐野义制药株式会社 萘啶衍生物
WO2012147763A1 (ja) 2011-04-26 2012-11-01 塩野義製薬株式会社 オキサジン誘導体およびそれを含有するｂａｃｅ１阻害剤
EP2912035A4 (en) 2012-10-24 2016-06-15 Shionogi & Co DERIVATIVES OF DIHYDROOXAZINE OR OXAZEPINE HAVING BACE1 INHIBITING ACTIVITY

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996041626A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
CA2224563A1 (en) * 1995-06-12 1996-12-27 G.D. Searle & Co. Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations
DK0880363T3 (da) * 1996-02-13 2003-01-20 Searle & Co Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger

Also Published As

Publication number Publication date
IS5430A (is) 2000-04-06
EP1027052A1 (en) 2000-08-16
TR200000928T2 (tr) 2000-11-21
IL135248A0 (en) 2001-05-20
SK4282000A3 (en) 2001-01-18
NO20001830L (no) 2000-05-10
EE200000192A (et) 2001-04-16
KR20010031017A (ko) 2001-04-16
PL339769A1 (en) 2001-01-02
AU9469398A (en) 1999-05-03
HUP0003874A2 (hu) 2001-05-28
US6046191A (en) 2000-04-04
CZ20001272A3 (cs) 2000-09-13
JP2001519391A (ja) 2001-10-23
MXPA00003445A (es) 2001-06-01
BR9812753A (pt) 2000-08-29
CN1281362A (zh) 2001-01-24
CA2305141A1 (en) 1999-04-22
NO20001830D0 (no) 2000-04-07
WO1999018960A1 (en) 1999-04-22

Similar Documents

Publication Publication Date Title
SE9802333D0 (sv) Novel combination
NO20001830L (no) Ny kombinasjon
PT971713E (pt) Utilizacao de inibidores da colinesterase para tratamento de desordens da atencao
YU53899A (sh) Primena inhibitora ciklooksigenaze-2 u prevenciji kardiovaskularnih poremećaja
MXPA04003668A (es) Inhibidores de fosfodiesteresa de tipo 4 y usos de los mismos.
NO20014303D0 (no) JAK-3-inhibitorer for behandling av allergiske lidelser
YU12097A (en) 6-phenilpyridyl-2-amine derivatives
NZ516562A (en) Pyrimidine-2,4,6-trione metalloproteinase inhibitors
EE200300559A (et) Osteopontiini kasutamine neuroloogiliste haigusteraviks ja/või vältimiseks
MXPA05009986A (es) Tratamiento de la enfermedad de alzheimer.
DK0973735T3 (da) Polyaromatiske antivirale præparater
PT1032414E (pt) Combinacao de um inibidor da enzima de conversao da angiotensina e de um diuretico para o tratamento de perturbacoes microcirculatorias
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
ATE249835T1 (de) Immunoregulator
HRP20031057B1 (hr) Tableta koja sadrži cetirizin i pseudoefedrin
CY1107039T1 (el) Αναστολεις τριπεπτιδυλ πεπτιδασης
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
PT1071463E (pt) Metodos e composicoes utilizando metabolitos de terfenadina em combinacao com inibidores de leucotrieno
HRP20050579B1 (hr) Nove sinergistiäśne kombinacije koje sadrže roflumilast i formoterol
IL139144A0 (en) Mycobacterial inhibitors
HRP20040071B1 (hr) Upotreba il-18 inhibitora u poremeä†ajima preosjetljivosti
NO20045343L (no) Ny kombinasjon for behandling av luftveisforstyrrelser
DK0774961T3 (da) Anvendelse af selegilin til behandling af epileptiske lidelser
ID20794A (id) Penggunaan inhibitor penukar natrium-hidrogen untuk pembuatan sediaan farmasi untuk pengobatan gangguan yang disebabkan oleh protozoa
BR0314364A (pt) Uso de inibidores de pde iv para tratar angiogênese